HLE Glascoat Limited order book reaches Rs 1,087 crore in Q2

HLE Glascoat Limited’s consolidated order book reached Rs 1,087.3 crore on September 30, 2026, its first close above Rs 1,000 crore, after about Rs 775 crore of Q2 FY27 order intake; management said the backlog was 51% higher year on year and 64% above the June 30 level.

What drove HLE Glascoat’s record order book?

HLE Glascoat’s order book rose because Q2 FY27 order intake exceeded the equipment executed during the quarter. Management said the order book increased by about Rs 425 crore from June 2026 to September 2026, while the company executed about Rs 350 crore of orders, implying total new orders of about Rs 775 crore during the three-month period.

A contributor was a contract secured by step-down subsidiary HLE Surface Technologies GmbH, Germany, for vitreous enamel cladding panels for the Germany-Denmark tunnel. Management said the contract would provide long-term revenue visibility, with supplies expected to start early or mid-next year and continue for three to three-and-a-half years.

The Rs 1,087.3 crore closing backlog was not presented as solely the result of the tunnel-panel project. Management linked wider order accretion to improving customer inquiries from pharmaceutical and specialty chemical industries, while several previously deferred projects were moving towards finalisation.

Which businesses generated HLE Glascoat’s Q2 revenue?

HLE Glascoat reported consolidated revenue from operations of Rs 346.7 crore in Q2 FY27, up 15.3% from Q1 FY27. Management said all three reported operating segments improved sequentially: filtration, drying and other equipment generated Rs 102 crore, glass-lined products generated Rs 195.4 crore, and heat-exchanger equipment generated Rs 48.8 crore.

Glass-lined products were the largest reported segment in Q2 FY27. Revenue of Rs 195.4 crore was 24.2% above Rs 157.3 crore in Q2 FY26, while H1 FY27 revenue in that segment increased 35.4%, according to management.

Heat-transfer equipment showed a different comparison: segment revenue declined 12.3% year on year but increased 362.3% quarter on quarter from a lower Q1 FY27 base. Filtration, drying and other equipment revenue increased 5.4% sequentially, from Rs 96.8 crore in Q1 FY27 to Rs 102 crore in Q2 FY27.

For H1 FY27, consolidated revenue was Rs 647.4 crore, compared with Rs 634.7 crore a year earlier, a 2% increase. The contrast between 2% H1 growth and 15.3% Q2 sequential growth reflects the slower first quarter and the improvement management said gained traction towards the end of Q2.

When could HLE Glascoat convert orders into revenue?

HLE Glascoat said its equipment execution cycle is normally four to seven months, and it records revenue only when equipment is dispatched to customers. Management therefore said the higher order flow should affect reported revenue and profit over the next two or three quarters rather than when an order is booked or an item is manufactured.

The company said Q1 and Q2 FY27 dispatches were marginally affected when customers postponed delivery acceptance because their own project implementation was delayed. Under HLE Glascoat’s revenue-recognition mechanism, equipment may be manufactured and ready for delivery but not reported as revenue until customer dispatch occurs.

The Germany-Denmark tunnel-panel contract has a longer supply schedule than typical equipment orders, with deliveries planned over three to three-and-a-half years. Management said the project adds multi-year visibility, whereas the four-to-seven-month cycle applies to much of the equipment business.

How are HLE Glascoat’s markets and subsidiaries performing?

HLE Glascoat described demand in India as optimistic, citing high demand from active pharmaceutical ingredient, or API, and specialty chemical customers. Management described European demand as somewhat subdued and demand from the United States as high; these comments concerned current order flow rather than reported revenue by geography.

The THALETEC product range accounted for about 22% of HLE Glascoat’s glass-lined products business in India during Q2 FY27. Management attributed the contribution to increasing domestic acceptance of the range, which had been introduced in India over the past few years.

Omeras reached earnings before interest, tax, depreciation and amortisation, or EBITDA, breakeven in H1 FY27, according to management. Management said it was working to ramp up the business after the six-month period, while noting that profit before tax remained marginally negative because of interest and depreciation.

The Indian glass-lined business generated about Rs 110 crore in H1 FY27 and achieved high-single-digit EBITDA margins, management said. It described that outcome as better than the prior year and said the Q3 and Q4 FY27 outlook was supported by the order book and current business visibility.

What do HLE Glascoat’s margins and working capital show?

HLE Glascoat reported Q2 FY27 EBITDA of Rs 39 crore, up 72.3% sequentially, on an EBITDA margin of 11.2%. Profit after tax was about Rs 16 crore, with a 4.6% margin, and management said profit after tax increased 680% from Q1 FY27.

The H1 FY27 comparison was less favourable than the Q2 trend. EBITDA was Rs 61.6 crore, compared with Rs 80 crore in H1 FY26, a 23% decline, while the EBITDA margin was 9.5% for the first six months.

Net working-capital days increased to 102 days from 80 days in FY26 as the order book expanded. Management said its response would focus on inventory management, disciplined receivables collection and optimisation of the cash-conversion cycle.

Management reaffirmed its previously discussed ambition of reaching a 15% consolidated EBITDA margin by FY28. It did not provide FY27 margin guidance, but said Q2’s 11.2% margin reflected progress and identified backlog execution, product mix and cost efficiencies as second-half priorities.

Conclusion

HLE Glascoat entered H2 FY27 with a Rs 1,087.3 crore order book, combining a multi-year tunnel-panel contract with improving order flows in pharmaceutical and specialty chemical markets. Q2 revenue of Rs 346.7 crore and EBITDA of Rs 39 crore improved sequentially, but H1 EBITDA of Rs 61.6 crore remained below Rs 80 crore a year earlier.

The next evidence point is execution over the next two or three quarters, given the four-to-seven-month equipment cycle and management’s plan to improve margins through product mix and cost efficiencies. Investors can also watch whether net working-capital days move from 102 days as management pursues inventory and receivables improvements, and whether Omeras advances beyond H1 FY27 EBITDA breakeven.